Revolutionary HIV Drug Could Mark the End of the AIDS Crisis

In this video, The Intellectualist dives into a groundbreaking report by NPR’s Goats and Soda (December 12, 2024) about lenacapavir, a revolutionary drug hailed as the 2024 Breakthrough of the Year by Science. Lenacapavir's twice-yearly injection promises to transform HIV prevention, with clinical trials showing astonishing results: 100% efficacy in one study and 96% in another. Learn how this innovation targets HIV’s capsid protein to block viral replication and why experts are calling it a potential game-changer. The stakes couldn't be higher: Sub-Saharan Africa, home to two-thirds of the global HIV burden, could see a dramatic reduction in cases, particularly among young women. But challenges remain. Lenacapavir’s current cost—$42,000 annually in the U.S.—poses significant barriers to accessibility. Experts emphasize the need for global collaboration to make this life-saving drug available to all, especially in low-income regions. Discover how lenacapavir could mark the beginning of the end for the AIDS epidemic and what steps are needed to turn this breakthrough into a global reality. 👉 Follow The Intellectualist:    / @theintellectualist   👉 Support The Intellectualist: https://buymeacoffee.com/theintellect... 👉 For more, check out the original article here: https://www.npr.org/sections/goats-an... #HIV #AIDS #MedicalBreakthrough #Lenacapavir #GlobalHealth